Embecta Corp. (EMBC)
USD 11.9
(-3.25%)
USD 11.9
(-3.25%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 245.4 Million USD | -37.01% |
| 2022 | 400.2 Million USD | -25.77% |
| 2021 | 530 Million USD | 1.13% |
| 2020 | 524 Million USD | -2.58% |
| 2019 | 538 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | 92.8 Million USD | -19.63% |
| 2024 Q1 | 51.2 Million USD | 22.2% |
| 2024 Q2 | 82 Million USD | 60.16% |
| 2023 Q4 | 44.4 Million USD | -19.57% |
| 2023 FY | - USD | -37.01% |
| 2023 Q3 | 55.2 Million USD | -6.91% |
| 2023 Q2 | 59.3 Million USD | -33.3% |
| 2023 Q1 | 88.9 Million USD | 67.11% |
| 2022 Q1 | 125 Million USD | 2.38% |
| 2022 FY | - USD | -25.77% |
| 2022 Q4 | 53.2 Million USD | -47.95% |
| 2022 Q3 | 102.2 Million USD | 3.44% |
| 2022 Q2 | 98.8 Million USD | -20.96% |
| 2021 Q1 | 124.1 Million USD | 0.0% |
| 2021 Q4 | 122.1 Million USD | -9.42% |
| 2021 Q3 | 134.8 Million USD | 4.9% |
| 2021 FY | - USD | 1.13% |
| 2021 Q2 | 128.5 Million USD | 3.55% |
| 2020 FY | - USD | -2.58% |
| 2019 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 308.32 Million USD | 20.409% |
| ANI Pharmaceuticals, Inc. | 109.32 Million USD | -124.479% |
| Dynavax Technologies Corporation | 9.66 Million USD | -2438.796% |
| Esperion Therapeutics, Inc. | -150.1 Million USD | 263.482% |
| Pacira BioSciences, Inc. | 162.89 Million USD | -50.647% |
| PainReform Ltd. | -9.56 Million USD | 2664.531% |
| Aquestive Therapeutics, Inc. | 1.18 Million USD | -20661.421% |
| Sunshine Biopharma, Inc. | -3.82 Million USD | 6516.663% |
| SCYNEXIS, Inc. | 73.47 Million USD | -233.973% |
| China SXT Pharmaceuticals, Inc. | -2.35 Million USD | 10538.067% |
| Cosmos Health Inc. | -17.06 Million USD | 1538.301% |
| Journey Medical Corporation | 1.92 Million USD | -12674.597% |
| Sunshine Biopharma, Inc. | -3.82 Million USD | 6516.663% |
| Safety Shot Inc | -12.18 Million USD | 2113.921% |
| Alpha Teknova, Inc. | -25.53 Million USD | 1060.883% |
| Intra-Cellular Therapies, Inc. | -158.85 Million USD | 254.482% |
| Bright Green Corporation | - USD | -Infinity% |
| Procaps Group, S.A. | 104.02 Million USD | -135.9% |
| Theratechnologies Inc. | -10.31 Million USD | 2479.568% |
| Harrow Health, Inc. | 9.72 Million USD | -2423.912% |
| Sonoma Pharmaceuticals, Inc. | -4.52 Million USD | 5523.204% |
| Biofrontera Inc. | -18.45 Million USD | 1429.865% |
| DURECT Corporation | -24.68 Million USD | 1094.166% |
| Supernus Pharmaceuticals, Inc. | 98.26 Million USD | -149.74% |
| Cronos Group Inc. | -72.14 Million USD | 440.129% |
| OptiNose, Inc. | -15.55 Million USD | 1677.831% |
| Ironwood Pharmaceuticals, Inc. | -924.86 Million USD | 126.534% |
| Kala Pharmaceuticals, Inc. | -36.08 Million USD | 780.118% |
| RedHill Biopharma Ltd. | 26.26 Million USD | -834.283% |
| Organogenesis Holdings Inc. | 36.03 Million USD | -581.08% |
| Guardion Health Sciences, Inc. | -3.92 Million USD | 6356.447% |
| Cumberland Pharmaceuticals Inc. | -710.85 Thousand USD | 34622.051% |
| Radius Health, Inc. | 38.31 Million USD | -540.564% |
| Universe Pharmaceuticals INC | -3.21 Million USD | 7732.807% |
| ProPhase Labs, Inc. | -14.82 Million USD | 1755.089% |
| Phibro Animal Health Corporation | 84.6 Million USD | -190.047% |
| Procaps Group S.A. | 104.02 Million USD | -135.9% |
| Alvotech | -484.86 Million USD | 150.612% |
| TherapeuticsMD, Inc. | -8.4 Million USD | 3021.081% |
| Viatris Inc. | 3.51 Billion USD | 93.021% |
| Rockwell Medical, Inc. | -4.69 Million USD | 5327.951% |
| Aytu BioPharma, Inc. | -1.01 Million USD | 24349.012% |
| SIGA Technologies, Inc. | 84.15 Million USD | -191.589% |
| Tilray Brands, Inc. | -72.84 Million USD | 436.889% |
| Lifecore Biomedical, Inc. | 812 Thousand USD | -30121.675% |
| Shineco, Inc. | -26.55 Million USD | 1024.158% |
| PetIQ, Inc. | 81.48 Million USD | -201.156% |
| Regencell Bioscience Holdings Limited | -3.61 Million USD | 6883.45% |
| Incannex Healthcare Limited | -18.5 Million USD | 1426.2% |
| Neurocrine Biosciences, Inc. | 416.1 Million USD | 41.024% |
| Alimera Sciences, Inc. | 7.27 Million USD | -3272.732% |
| Silver Spike Investment Corp. | 7.34 Million USD | -3243.274% |
| Assertio Holdings, Inc. | -222.44 Million USD | 210.318% |
| Shuttle Pharmaceuticals Holdings, Inc. | -3.99 Million USD | 6249.376% |
| Petros Pharmaceuticals, Inc. | -4.21 Million USD | 5926.389% |
| Clever Leaves Holdings Inc. | -16.8 Million USD | 1560.367% |
| Cyclo Therapeutics, Inc. | -20.03 Million USD | 1325.114% |
| Avadel Pharmaceuticals plc | -149.12 Million USD | 264.56% |
| Hempacco Co., Inc. | -12.77 Million USD | 2021.2% |
| Talphera, Inc. | -9.84 Million USD | 2593.396% |
| Alvotech | -484.86 Million USD | 150.612% |
| Eagle Pharmaceuticals, Inc. | 77.5 Million USD | -216.637% |
| Lantheus Holdings, Inc. | 491 Million USD | 50.021% |
| Currenc Group, Inc. | -1.9 Million USD | 13011.889% |
| Kamada Ltd. | 21.53 Million USD | -1039.593% |
| Indivior PLC | 66 Million USD | -271.818% |
| Evoke Pharma, Inc. | -7.29 Million USD | 3465.196% |
| Flora Growth Corp. | -45.87 Million USD | 634.99% |
| Cyclo Therapeutics, Inc. | -20.03 Million USD | 1325.114% |
| Evolus, Inc. | -41.81 Million USD | 686.941% |
| HUTCHMED (China) Limited | 25.52 Million USD | -861.297% |
| Amphastar Pharmaceuticals, Inc. | 241.46 Million USD | -1.63% |
| Akanda Corp. | -27.73 Million USD | 984.781% |